Artigo · Revista · 2021

A multi-target drug designing for BTK, MMP9, proteasome and TAK1 for the clinical treatment of mantle cell lymphoma

Sanjeev Singh

Current Topics in Medicinal Chemistry

• Acesso fechado

Ir para a editora10.2174/1568026621666210119112336